Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(1):1; doi:10.1093/jnci/96.1.1
© 2004 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Arnold, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Arnold, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

Press Release

Active Smoking Associated With Increased Risk of Breast Cancer

Katherine Arnold, News Editor

jncimedia{at}oupjournals.org

Active smoking appears to play a larger role in the development of breast cancer than previously thought, according to a study in the January 7 issue of the Journal of the National Cancer Institute.

Tobacco smoke contains a number of human carcinogens, and metabolites of cigarette smoke have been found in the breast fluid of smokers. However, studies examining the association between tobacco smoke and breast cancer risk have yielded inconsistent results. Many studies have not been able to independently assess the contributions of the timing of exposure, age of diagnosis, or genetic susceptibilities to the overall risk of breast cancer. In addition, many of these studies did not consider passive smoking exposures, or exposure to secondhand smoke, among nonsmokers.

Peggy Reynolds, Ph.D., of the California Department of Health Services, and her colleagues examined breast cancer risk among 116,544 women in the California Teachers Study who had reported their smoking status on a survey given to them when they enrolled in the study.

Between 1996 and 2000, 2,005 of the women were diagnosed with invasive breast cancer. The incidence of breast cancer among current smokers was approximately 30% greater than that among women who had never smoked, irrespective of whether they were compared to women who had or had not been exposed to passive smoking. Analysis of subgroups of active smokers revealed increased breast cancer risks among women who started smoking before age 20, who began smoking at least 5 years before their first full-term pregnancy, and who had a longer duration of smoking or who smoked 20 or more cigarettes per day.

Current smoking was associated with increased breast cancer risk in women without a family history of breast cancer but not among women with a family history of the disease. There was no statistically significant increase in breast cancer risk among former smokers, and there was no evidence of an association between passive smoking exposure and breast cancer risk.

"Our results, which suggest that active smoking may be associated with an increased risk of breast cancer, argue for further research that can account for heterogeneity in individual susceptibility," the authors write. "Exposures to tobacco smoke, if causally related to breast cancer, could offer one of the few available modifiable avenues for preventing this disease."

    ###

Contact: Ken August, California Department of Health Services, 916-440-7660; kaugust{at}dhs.ca.gov.

Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, et al. Active smoking, household passive smoking, and breast cancer: Evidence from the California Teachers Study. J Natl Cancer Inst 2003;96:29–37.

Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jncicancerspectrum.oupjournals.org/.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. W. Simons, M. A. Carducci, B. Mikhak, M. Lim, B. Biedrzycki, F. Borellini, S. M. Clift, K. M. Hege, D. G. Ando, S. Piantadosi, et al.
Phase I/II Trial of an Allogeneic Cellular Immunotherapy in Hormone-Naive Prostate Cancer.
Clin. Cancer Res., June 1, 2006; 12(11): 3394 - 3401.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Arnold, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Arnold, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?